Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    POP6792
Show Display Options
Rank Status Study
1 Completed Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
Condition: Neoplasm Malignant
Intervention: Drug: Cabazitaxel (XRP6258)

Study has passed its completion date and status has not been verified in more than two years.